The FDA did state that there had been post-marketing reports of cases sleep disorders and behavior changes, though did not report incidence
High cortisol levels have been observed in depressed patients [81] , and the observed increased levels of corticosterone in treated mice ( Fig
We were never told this was a possibility and it took me 8 months and almost losing my son to figure it out
This study confirms the concern of a high prevalence of adverse neuropsychiatric effects among patients receiving montelukast, especially agitation, sleep disturbance, pain, and hyperactivity
Neuropsychiatric reactions with the use of montelukast BMJ
Tips
In 2019, the National Center for Health Research testified before the FDA about these neuropsychiatric side effects, urging that the FDA require a brief and easy-to-understand FDA officials say the potential for serious side effects from Singulair “We are unaware of any other allergy/asthma medications that have this neuropsychiatric side effect
cold symptoms such as runny or stuffy nose, sinus pain, cough, sore throat
These postmarketing reports have been
Most reported cases of neuropsychiatric events occurred during montelukast treatment Tiredness